The groundbreaking therapy of the medication represents a significant advance in the management of the condition. Distinct from existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide443372.iyublog.com/40738019/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment